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Abstract
The complement C3-like protein TEP1 of the mosquito Anopheles gambiae is required for defense against malaria parasites
and bacteria. Two forms of TEP1 are present in the mosquito hemolymph, the full-length TEP1-F and the proteolytically
processed TEP1cut that is part of a complex including the leucine-rich repeat proteins LRIM1 and APL1C. Here we show that
the non-catalytic serine protease SPCLIP1 is a key regulator of the complement-like pathway. SPCLIP1 is required for
accumulation of TEP1 on microbial surfaces, a reaction that leads to lysis of malaria parasites or triggers activation of a
cascade culminating with melanization of malaria parasites and bacteria. We also demonstrate that the two forms of TEP1
have distinct roles in the complement-like pathway and provide the first evidence for a complement convertase-like
cascade in insects analogous to that in vertebrates. Our findings establish that core principles of complement activation are
conserved throughout the evolution of animals.
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Introduction
The mosquito Anopheles gambiae is the main vector of Plasmodium
falciparum malaria in sub-Saharan Africa and hence directly
responsible for the death of hundreds of thousands of people
every year and for a devastating socioeconomic burden especially
in endemic countries. Mosquitoes launch a potent immune attack
leading to the killing of the majority of invading Plasmodium
parasites. Multiple mechanisms are thought to participate in
these anti-Plasmodium reactions, amongst them a latent pathway
resembling vertebrate complement [1]. RNAi knockdown (kd)
studies, based on the injection of double stranded RNA (dsRNA)
into adult A. gambiae mosquitoes, have revealed important roles of
components of the complement-like pathway in defense against
the murine malaria parasite Plasmodium berghei [2–6]. There is also
significant evidence for a role of this pathway in defense against
the human parasite, P. falciparum, in laboratory infections of A.
gambiae [3,7–9].
Recent studies with natural A. gambiae populations revealed
that the gene encoding the C3-like protein TEP1, a key player of
the complement-like pathway, and the genomic locus encoding
its interacting partner APL1C are under strong directional
selection in an M form population but subject to balancing
selection in another S form population [10,11]. Despite the fact
that distinct TEP1 alleles have been associated with resistance to
Plasmodium parasites [2,8,11–13], the selective pressure on TEP1 is
hypothesized to be driven by pathogens in larval habitats rather
than those encountered by adults. This is further supported by the
rather generic immune specificity of TEP1 that functions also in
anti-bacterial [3,14] and anti-fungal defense [15]. The polymor-
phic nature of TEP1 also suggests that the different alleles might
follow different kinetics in interacting with LRIM1/APL1C as well
as other TEP1 regulatory proteins, which could influence the
efficiency of parasite killing or microbial clearance. Therefore, a
better understanding of the mechanisms regulating complement
activation and identification of the proteins involved will permit
deciphering the functional relevance to Plasmodium of allelic
interactions within this immune module on resistance.
The hallmark of activation of the mosquito complement-like
pathway is the binding of TEP1 to microbial surfaces through a
thioester bond, a reaction that is tightly linked to microbial killing
[14]. TEP1 circulates in the mosquito hemolymph in two forms:
the full-length form TEP1-F and the proteolytically processed
form TEP1cut, corresponding to pro-C3 and the mature C3
protein after processing in the ER, respectively [14,16]. Unlike
C3, TEP1 lacks an anaphylatoxin domain and the exposed
thioester bond of TEP1cut is unstable [17]. TEP1cut is stabilized in
the hemolymph through interactions with a heterodimer of the
leucine-rich repeat (LRR) proteins LRIM1 and APL1C, which
seems to confer specificity upon TEP1 activity [5,16]. While the
structure and function of TEP1 and its C3 homolog are largely
conserved from insects to mammals, LRIM1 and APL1C are
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thought to be specific to mosquitoes [18] raising interesting
questions about the degree of structural and/or functional
conservation between other modules of the complement pathway
such as those that stabilize or amplify complement on microbial
surfaces. The research presented here aimed to address these
questions and provide novel mechanistic insights into the
activation of the mosquito complement pathway during infection.
Results
SPCLIP1 is a component of the complement-like pathway
To identify novel components of the mosquito complement
pathway, we searched for genes that exhibited significant co-
regulation with LRIM1 in a developmental transcriptome dataset
of Expressed Sequence Tags (ESTs; [19]). Pearson correlation
coefficient (PCC) identified 4 EST clusters showing similarity to
LRIM1 developmental expression greater than 0.95. Importantly,
3 of the 4 clusters were found to encode proteins that had
been previously shown to physically interact with LRIM1,
including APL1C (PCC 0.964), TEP1 (PCC=0.978) and
TEP4 (PCC=0.965) [5,16,20]. The fourth EST cluster
(PCC=0.980) did not correspond to any gene model in the A.
gambiae genome. It encodes a protein with CLIP and serine
protease domains, previously identified as SPCLIP1 and shown to
be involved in defense against P. falciparum, P. berghei, Escherichia coli
and Staphylococcus aureus [3]. SPCLIP1 maps within a genomic
region encompassing 12 additional genes encoding proteins with
CLIP and serine protease domains (Figure S1A). All residues
corresponding to the serine protease catalytic triad (Asp-His-Ser)
are substituted in SPCLIP1 indicating that it is non-catalytic
(Figure S1B). Phylogenetic analysis places SPCLIP1 in the highly
divergent CLIPE subfamily of non-catalytic CLIP-domain serine
protease homologs (SPHs; Figure S1C).
Co-regulation with LRIM1 and the previously reported knock-
down phenotypes [3] were suggestive of SPLCLIP1 involvement
in the A. gambiae complement-like pathway. To characterize
SPCLIP1, we raised a polyclonal antibody against the entire
protein and used it in western blots of adult mosquito hemolymph
separated by non-reducing SDS-PAGE. The results showed that
SPCLIP1 migrates at approximately 45 kDa, near its predicted
42 kDa molecular weight (Figure 1A). We examined whether the
steady state levels of SPCLIP1 in the hemolymph are affected
by silencing LRIM1 or TEP1. While TEP1 kd had no effect on
SPCLIP1 levels, these were markedly reduced in LRIM1 kd
(Figure 1B). This decrease of SPCLIP1 parallels the near complete
loss of TEP1cut from the hemolymph of LRIM1 or APL1C kd
mosquitoes due to its accumulation on self-tissues (Figure 1B)
[5,16]. To determine if the reduction of SPCLIP1 in LRIM1 kd
is dependent on TEP1, we silenced LRIM1 and TEP1 simulta-
neously. Under these conditions, SPCLIP1 was restored to its
baseline levels (Figure 1C). In contrast, silencing LRIM1 and
SPCLIP1 together did not restore TEP1cut levels, suggesting that
SPCLIP1 functions downstream of TEP1cut, and that in LRIM1 kd
mosquitoes SPCLIP1 is likely to be sequestered on self-tissues
together with TEP1cut.
SPCLIP1 and TEP1 localization to ookinetes is mutually
dependent
We investigated the role of SPCLIP1 in TEP1 binding to P.
berghei. It has been previously established that TEP1 binds to the
surface of P. berghei ookinetes as they traverse the mosquito midgut
epithelium and come into contact with the hemolymph [2]. In
SPCLIP1 kd mosquitoes, TEP1 staining on the ookinete surface
was inhibited (Figure 2A). This, together with the TEP1-
dependent reduction of SPCLIP1 from the hemolymph following
LRIM1 kd, led us to hypothesize that SPCLIP1 is recruited to the
parasite surface during infection. To test this, SPCLIP1 was
immunolocalized in midgut epithelium 26 h after infection. We
observed robust SPCLIP1 signal on dead ookinetes, judged by the
Figure 1. SPCLIP1 is a component of the mosquito complement
cascade. (A) Western analysis of mosquito hemolymph collected 4
days after injection with LacZ or SPCLIP1 dsRNA. The blot was initially
probed with a polyclonal antibody raised against recombinant SPCLIP1
(top panel) and re-probed with an APL1C antibody (bottom panel) to
confirm equal loading. (B)(C) Mosquito hemolymph collected 4 days
after injection of LacZ dsRNA or silencing SPCLIP1, LRIM1 or TEP1 (or
combinations of those) was analyzed by western blot using SPCLIP1,
APL1C and TEP1 antibodies. Blots were re-probed with SRPN3 and PPO6
antibodies to confirm equal loading. The labels on the right indicate
protein or complex detected. Images are representative of three
independent biological replicates.
doi:10.1371/journal.ppat.1003623.g001
Author Summary
Mosquitoes are vectors of numerous human diseases
including malaria. Disease transmission requires that
microbes overcome the robust mosquito immune system.
In the African malaria mosquito, the TEP1 protein that is
homologous to mammalian complement factor C3 is
shown to play a central role in mosquito immunity to
malaria parasites and bacteria. In this study, we report that
another mosquito protein belonging to a class of non-
catalytic enzymes that are specific to arthropods is a core
component of the mosquito complement-like immune
pathway. We found that this new protein, named SPCLIP1,
regulates the accumulation of TEP1 on malaria parasites
and bacteria, and show that this can lead to distinct
defense reactions including lysis and melanization of the
pathogen. This work is valuable because it reveals novel
insight into the regulation of mosquito complement on
microbial surfaces such as those of the malaria parasites.
Unraveling the molecular mechanisms regulating these
defense responses may ultimately lead to the design of
novel disease blocking strategies in the vector.
SPCLIP1 Regulates Mosquito Complement Recruitment
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loss of their cytoplasmic GFP signal (Figure 2B). Given that TEP1
is also highly prevalent on dead ookinetes, this result indicates that
SPCLIP1 and TEP1 likely co-localize to the same ookinetes;
however, we could not simultaneously assay their distribution since
both antibodies were raised in the same host species. No SPCLIP1
staining was observed in midgut epithelia dissected from SPCLIP1
kd mosquitoes, showing that the antibody is specific. Importantly,
SPCLIP1 staining on the ookinete surface was inhibited after
TEP1 kd. This suggests that the localization of TEP1 and
SPCLIP1 to ookinetes is mutually dependent (Figure 2B).
SPCLIP1 is required for the utilization of TEP1-F
TEP1 present on microbial surfaces during infection may
originate either from the TEP1cut or the TEP1-F pools. To clarify
this point and investigate further the functional relationship
between the two forms of TEP1 and SPCLIP1, we developed an
alternative infection model that allowed us to monitor temporally
and quantitatively the dynamics of the examined proteins after
injection of E. coli bioparticles (chemically killed bacteria) into the
hemocoel. This infection model offers the advantage of tight
temporal monitoring of rapid immune responses such as those of
complement, which occur within minutes of microbial exposure to
the hemolymph. Hemolymph was collected from groups of
mosquitoes at 15, 60, 120, 240 and 360 minutes post injection
with bacteria or PBS (i.e. control) and proteins were analyzed
by western blot. The results showed strong reduction in SPCLIP1,
the LRIM1/APL1C complex, and TEP1-F levels in mosquito
hemolymph after injection of E. coli bioparticles (Figure 3A). A
marked reduction of these proteins was already observed at
60 min after injection and persisted up to 240 min when LRIM1/
APL1C and TEP1-F levels began to rise. The kinetics of TEP1-
F reduction demonstrate that this form of TEP1 is consumed
quickly in the immune response to infection, in contrast to
TEP1cut, which does not seem to vary significantly during that
process, at least within the examined timeframe. In addition to the
well-defined TEP1-F and TEP1cut bands, we also observed a
broadly stained TEP1-specific smear at 50–60 kDa exhibiting
depletion kinetics following bioparticle challenge similar to that of
TEP1-F (Figure 3A). These C-terminal TEP1 fragments have been
previously described [14]; whether they represent functional forms
of TEP1 or are products of TEP1-F turnover remains to be
determined.
LRIM1/APL1C and SPCLIP1 exhibited similar depletion
kinetics as TEP1-F following bioparticle injections (Figure 3A),
suggesting that these proteins are either required for TEP1-F
utilization or are independently consumed in the immune
reactions. To address this, we monitored the effect of SPCLIP1
silencing on the infection-dependent depletion of TEP1-F.
Western blot analysis of hemolymph collected from SPCLIP1
and control LacZ kd mosquitoes challenged with E. coli bioparticles
demonstrated that the loss of TEP1-F is abolished in SPCLIP1 kd
mosquitoes compared to controls (Figure 3B), indicating that
SPCLIP1 acts upstream of TEP1-F and is indeed required for the
infection-induced loss of this protein. In contrast, the depletion of
LRIM1/APL1C was not restored in the hemolymph of SPCLIP1
kd mosquitoes. Together, these data suggest that activation of
mosquito complement by the LRIM1/APL1C/TEP1cut complex
is a separate event upstream of the SPCLIP1-dependent comple-
ment amplification process that is poised to transform initial
pathogen recognition into a robust attack.
SPCLIP1 is required for TEP1-F to TEP1cut conversion on
microbial surfaces
An important aspect of the complement system is its specific
activation on microbial surfaces. In order to address whether the
observed reduction in SPCLIP1 and TEP1-F levels in the
hemolymph after injection of E. coli bioparticles is due to their
sequestration on bioparticle surfaces, we designed an assay that
allows quantitative assessment of E. coli-bound versus hemolymph
soluble pools of these proteins. E. coli bioparticles were injected
into mosquito hemocoel, and hemolymph was extracted 15 min
after injection. Bioparticles were separated from the hemolymph
by centrifugation, washed extensively and their surface-bound
proteins eluted for western blot analysis (Figure 4A). The results
showed that SPCLIP1 was present in the E. coli-bound fraction
in dsLacZ control mosquitoes (Figure 4B), which explains its
reduced levels in the hemolymph after bacterial challenge and
is consistent with its localization to ookinetes. In TEP1 kd
mosquitoes, SPCLIP1 was lost from the E. coli-bound fraction and
became enriched in the soluble fraction, indicating that TEP1 is
required for SPCLIP1 recruitment to bacterial surfaces.
This assay also allowed us to monitor which of the two forms of
TEP1 associates with the bacterial surface. In dsLacZ treated
mosquitoes, TEP1-F was not detected in the E. coli-bound fraction,
despite being almost fully depleted from the soluble material, in
contrast to TEP1cut, which was clearly present. These data are
Figure 2. TEP1 and SPCLIP1 localization on dead parasites is
mutually dependent. (A) TEP1 immunolocalization on the surface of
GFP-expressing P. berghei parasites invading the mosquito midgut 26 h
after infection. TEP1 positive parasites (arrows) do not express GFP and
appear fragmented indicating that they are killed, while TEP1 negative
parasites express GFP and are considered live. There is a dramatic
reduction in TEP1 signal in mosquitoes treated with dsSPCLIP1. Lack of
TEP1 signal in dsTEP1 treated mosquitoes confirms the specificity of the
antibody. A rare TEP1, GFP double positive parasite is visible in the
upper left panel of the dsLacZ control. (B) SPCLIP1 immunolocalization
on the surface of GFP-expressing P. berghei parasites invading the
mosquito midgut epithelium 26 h after infection. SPCLIP1 positive
parasites (arrows) are fragmented and lack GFP signal indicating they
are dead. There is a dramatic reduction in SPCLIP1 signal in mosquitoes
treated with dsTEP1. Lack of SPCLIP1 signal in the dsSPCLIP1 treated
mosquitoes confirms the specificity of the antibody. The background
staining observed in all panels is non-specific antibody trapping by the
trachea and muscle fibers present on the basolateral surface of the
mosquito midgut. For both TEP1 and SPCLIP1 immunolocalization
assays two independent biological replicates were performed with 5–10
midguts for each dsRNA. Panels are representative confocal projections
of an approximately 20 mm thick section of the midgut basolateral
surface. The scale bar is 10 mm.
doi:10.1371/journal.ppat.1003623.g002
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consistent with those reported previously using a cell culture assay
and showing that bacteria only bound TEP1cut when incubated
with the conditioned medium of a hemocyte-like cell line that
contained both forms of TEP1 [14]. Importantly, TEP1cut signal
in the bound material was dramatically reduced by SPCLIP1 kd,
concomitant with the detection of TEP1-F in the soluble fraction.
These data indicate that TEP1cut accumulating on the surface of
E. coli is generated from TEP1-F and that its conversion requires
recruitment of SPCLIP1 and a yet unidentified protease to the
bacterial surface.
Microbial infection promotes SPCLIP1 interaction with
TEP1
The functional association between SPCLIP1 and TEP1
including their cooperative recruitment to microbial surfaces
suggested that these two proteins might physically interact. To
examine this possibility, we performed an immunoprecipitation
(IP) assay on hemolymph samples collected from mosquitoes
following challenge with E. coli bioparticles using beads cross-
linked to an affinity purified SPCLIP1 antibody. IP beads lacking
antibody and mock bioparticle challenge (PBS injection) served as
controls. The results revealed that SPCLIP1 was less abundant in
the unbound fraction and significantly enriched in the bound
fraction (Figure 5). In contrast, SPCLIP1 was not detected on
control beads and the protein remained highly abundant in the
unbound fraction. When samples were probed for TEP1, a signal
for TEP1cut and a faint but clear TEP1-F signal were observed in
the SPCLIP1 IP bound fraction. These bands were detectable only
in samples collected from bioparticle challenged mosquitoes.
These data indicate that SPCLIP1 and TEP1 can interact and that
this interaction is induced by infection. These data raise the
Figure 3. SPCLIP1 is required for the utilization of TEP1-F. (A) Western blot analysis of hemolymph collected from mosquitoes after injection
with PBS (left) or E. coli bioparticles (right) using a panel of different antibodies. Full-length and processed TEP1 are indicated as TEP1-F and TEP1cut,
respectively. Re-probing with SRPN3 was used to confirm equal loading. (B) Western blot analysis of hemolymph collected from control LacZ dsRNA-
injected (left) and SPCLIP1 kd (right) mosquitoes after injection with E. coli bioparticles. Re-probing with PPO6 was used to confirm equal loading.
Images are representative of three independent biological replicates.
doi:10.1371/journal.ppat.1003623.g003
Figure 4. SPCLIP1 and TEP1cut are localized on the surface of E.
coli bioparticles. (A) Schematic overview of sample preparation.
Hemolymph containing E. coli bioparticles was recovered 15 min after
injection into mosquitoes after gene silencing. The bacteria were
separated by centrifugation and the soluble fraction was collected. The
bacterial pellet was washed with buffer and extracted for analysis. (B)
Western blot analysis of soluble and bioparticle bound fractions using
antibodies against TEP1 and SPCLIP1. Images are representative of two
independent biological replicates.
doi:10.1371/journal.ppat.1003623.g004
Figure 5. SPCLIP1 and TEP1 interact after challenge with E. coli
bioparticles. IP beads containing SPCLIP1 antibody or control beads
were used to capture proteins from hemolymph 15 min after injection
with E. coli bioparticles (+) or PBS (2). The beads were separated and
samples of the unbound and bound fractions were analyzed by western
blot under reducing and non-reducing conditions for TEP1 and SPCLIP1,
respectively. Images are representative of two independent biological
replicates.
doi:10.1371/journal.ppat.1003623.g005
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possibility that these proteins interact first in the hemolymph
prior to their localization on microbial surfaces. Alternatively,
membrane-bound complexes containing TEP1 and SPCLIP1 may
leach off the surface during sample preparation. Whether this
interaction is direct or mediated by another factor remains to be
determined.
SPCLIP1 is required for activation of the melanization
cascade
It has been previously shown that bacterial inoculation into
the mosquito hemolymph leads to rapid activation cleavage of
CLIPA8, a key SPH regulator of bacteria [21] fungi [15], and
Plasmodium melanization [22]. We examined whether SPCLIP1 is
required for CLIPA8 activation in the mosquito hemolymph
following E. coli bioparticle injection. As shown in Figure 6A,
silencing SPCLIP1 inhibited completely CLIPA8 cleavage, sug-
gesting that SPCLIP1 is required for activation of the melanization
cascade.
The final steps of melanization are catalyzed by phenoloxidase
(PO) which is secreted as a pro-enzyme (PPO) and activated by
proteolytic cleavage in response to infection. We directly examined
whether SPCLIP1 is essential for PPO activation by monitoring
PO activity in the mosquito hemolymph after bacterial injection.
Indeed, SPCLIP1 kd resulted in a strong decrease in PO activity
relative to dsLacZ-injected controls, which is comparable to that
observed in CLIPA8 kd mosquitoes (Figure 6B). Similar to
SPCLIP1 kd, silencing TEP1 also resulted in strong inhibition of
both CLIPA8 cleavage and PPO activation (Figure S2). These
data demonstrate that activation of the melanization cascade is
dependent on SPCLIP1-mediated TEP1 accumulation on the
bacterial surface.
We next tested the function of SPCLIP1 in P. berghei melani-
zation using as a model CTL4 kd mosquitoes which melanize
nearly all ookinetes soon after they traverse the mosquito midgut
and before they develop into oocysts [4]. Indeed, silencing CTL4
alone resulted in a marked decrease of the oocyst numbers and a
reciprocal increase in melanized ookinetes, but concomitant
silencing of SPCLIP1 completely blocked ookinete melanization
and led to an increase in oocysts comparable to that of SPCLIP1 kd
alone (Figure 6C). A similar inhibition of parasite melanization has
been observed after silencing TEP1 or LRIM1/APL1C [2,4,5].
These data reveal that, as with bacterial melanization, SPCLIP1-
mediated accumulation of TEP1 on the ookinete surface is
required for parasite melanization.
Discussion
Here we characterize SPCLIP1, a non-catalytic CLIP-domain
serine protease of the malaria vector mosquito A. gambiae, which
localizes to the surface of P. berghei ookinetes and E. coli promoting
rapid accumulation of the complement C3-like protein TEP1. Our
results demonstrate that SPCLIP1 regulates a complement
convertase-like activity henceforth referred to as TEP1 convertase.
The TEP1 convertase is functionally analogous to the vertebrate
C3 convertase, the formation of which is triggered by binding of
antibodies or innate pattern recognition proteins on the microbial
surfaces, or by spontaneous activation of C3 following hydrolysis
of its thioester. The trigger for the formation of the TEP1
convertase is thought to be the binding on the microbial surface of
TEP1cut which circulates in the mosquito hemolymph together
with the LRIM1/APL1C complex (Figure 7). LRIM1 and APL1C
possess LRR domains, a feature that is versatile in its binding
properties and common in pattern recognition receptors
involved in host defense in animals and plants [23]. Therefore,
the LRIM1/APL1C complex may play a dual role in the mosquito
complement-like pathway by stabilizing TEP1cut in the hemo-
lymph and delivering it to the microbial surface upon infection.
Given that the LRIM1 and APL1C belong to a mosquito-specific
family of LRR proteins [5] whereas TEPs are widely conserved
[24], different triggers of complement activity are likely to exist in
other insects. A number of different putative pattern recognition
receptors have been identified to play a role in TEP1-dependent
defense against bacteria and malaria parasites [4,6,25–27] raising
the possibility that mosquitoes may also have multiple recognitions
systems that can activate the TEP1 convertase. It has been
proposed that nitration of malaria parasites during their passage
through the mosquito midgut epithelium is required for TEP1
binding [28]. Whether microbe nitration can trigger recognition
by LRIM1/APL1C or other putative recognition receptors
remains to be determined.
A study using recombinant proteins and an allele of TEP1 from
mosquitoes that are refractory to Plasmodium has shown that
the LRIM1/APL1C complex binds TEP1cut lacking an intact
thioester, and that TEP1cut precipitates out of solution in the
absence of LRIM1/APL1C [17]. A more recent study using a
TEP1cut allele from susceptible mosquitoes has revealed that the
Figure 6. SPCLIP1 is required for triggering the melanization
cascade. (A) Reducing western blot analysis of CLIPA8 in hemolymph
collected from control LacZ dsRNA-injected (top) and SPCLIP1 kd
mosquitoes (bottom) after injection with E. coli bioparticles. Full-length
and cleaved CLIPA8 are labeled CLIPA8-F and CLIPA8-C, respectively.
Images are representative of two independent biological replicates. (B)
PO activity measured in hemolymph samples collected from dsLacZ,
dsSPCLIP1 and dsCLIPA8 treated mosquitoes 6 h after injection with
bacteria. Data are representative of two independent biological
replicates. See also Figure S2. (C) GFP-expressing P. berghei oocysts
(green circles) and melanized ookinetes (gray squares) in dsLacZ,
dsSPCLIP1, dsCTL4 and dsCTL4/dsSPCLIP1 injected mosquitoes 7 days
post infection were counted. Lines indicate median infection intensity
values. Data were combined from three independent biological
replicates. For statistical analysis, dsCTL4 and dsSPCLIP1 injected
mosquitoes were compared to dsLacZ while dsCTL4/dsSPCLIP1 injected
mosquitoes were compared to dsCTL4. Asterisks indicate Kruskal-Wallis
P-values,0.01.
doi:10.1371/journal.ppat.1003623.g006
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LRIM1/APL1C complex can interact with TEP1cut with an active
thioester [29]. These in vitro studies have led the authors to
speculate that a complex between LRIM1/APL1C and TEP1cut
may function in vivo as a TEP1 convertase. It remains unknown
whether TEP1cut lacks an intact thioester in vivo, and whether its
localization on mosquito tissues in the absence of LRIM1/APL1C
is the result of protein precipitation or autoimmune attack by an
active thioester motif [5,16]. The TEP1cut dependent SPCLIP1
depletion favors the hypothesis of an autoimmune attack that is
tightly regulated to prevent collateral damage to host tissues.
Indeed, SPCLIP1 loss from the hemolymph following artificial
induction of TEP1cut attack of self-tissues is not accompanied by
TEP1-F depletion, suggesting that downstream negative regulators
prevent the full formation of the TEP1 convertase and/or that
additional positive factors similar to vertebrate properdin may be
required to stabilize the convertase on microbial surfaces.
SPCLIP1 lacks catalytic serine protease activity and likely acts
as a regulatory component of the TEP1 convertase. Hence, an
unidentified protease and possibly other factors are expected to
also contribute to the mature convertase, catalyzing the activation
cleavage of TEP1-F. The role of non-catalytic serine proteases as
cofactors for active proteases is well documented in insects with
examples from Holotrichia diomphalia [30], Manduca sexta [31] and
Drosophila melanogaster [32].
The SPCLIP1-dependent rapid loss of TEP1-F from the
hemolymph of bioparticle injected mosquitoes and the observation
that SPCLIP1 kd in naive mosquitoes does not alter TEP1-F levels,
suggests that the TEP1cut cargo circulating as a complex with
LRIM1/APL1C is generated through a different mechanism than
that produced by the TEP1 convertase. Of note, while bioparticle
injection almost depletes TEP1-F from the hemolymph, only a
minor reduction in TEP1cut levels is observed most significantly
at 60 min post injection. A plausible explanation for this
observation is that TEP1-F is converted to TEP1cut prior to
binding the bacterial surface, a fraction of which remains soluble
in the hemolymph throughout the timeframe of the experiment.
Regardless of the activation mechanism, the C3 and TEP1
convertases function in very similar ways to recruit additional C3
and TEP1, respectively, from precursor pools onto the microbial
surface, and to initiate diverse effector cascades. In vertebrates,
accumulation of the C3 cleavage product, C3b, on microbial
surfaces triggers phagocytosis as well as assembly of the membrane
attack complex that causes microbial lysis. In mosquitoes, in
addition to triggering phagocytosis of bacteria [14,33] and lysis of
malaria parasites [2,3], TEP1 accumulation on microbial surfaces
triggers the PO cascade leading to melanization. Therefore, the
strategy of complement driving diverse effector functions is ancient
and not specifically co-opted by vertebrates. It remains to be
further investigated whether this system is indeed an example of
convergent evolution rooted to the functional conservation of
thioester-containing proteins, a hypothesis consistent with our
earlier findings that this pathway appears to have evolved de novo in
each mosquito species by ‘‘bricolage’’ assemblages of the most
suitable available components [34].
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the United
Kingdom Animals (Scientific Procedures) Act 1986. The protocols
for maintenance of mosquitoes by blood feeding and for infection
of mosquitoes with P. berghei by blood feeding on parasite-infected
mice were approved and carried out under the UK Home Office
License PLL70/7185 awarded in 2010. The procedures are of
mild to moderate severity and the numbers of animals used are
minimized by incorporation of the most economical protocols.
Opportunities for reduction, refinement and replacement of
animal experiments are constantly monitored and new protocols
are implemented following approval by the Imperial College
Ethical Review Committee.
Mosquito maintenance, gene silencing and infection
A. gambiae G3 strain was maintained and assayed for infection
with P. berghei CONGFP strain as described previously [20]. Single
and double knockdown experiments and parasite counts in
dissected midguts were performed as described previously [5].
Primers used for synthesis of double stranded RNA have been
reported elsewhere LRIM1, TEP1, CTL4 [4,35]; SPCLIP1 [3].
Generation and purification of SPCLIP1 antibody
The entire SPCLIP1 open reading frame lacking the endogenous
signal peptide and stop codon was cloned into the pIEx10 insect
cell expression plasmid (Novagen) incorporating a C-terminal 106
HIS-tag using the primers:
For: GACGACGACAAGATGAACTTCCCCGTTGGGAA
ATTTC
Rev: GAGGAGAAGCCCGGTTTATCGAAGCTGATCG-
GATCGGG
The underlined sequences are extensions to allow ligase-
independent cloning [5]. Sf9 cells adapted for growth in
Figure 7. Model of TEP1 convertase formation. In steady state hemolymph a pool of TEP1-F is processed by an unknown protease to generate
TEP1cut, which interacts and circulates with the LRIM1/APL1C complex. Recognition of microbial surfaces leads to deposition of LRIM1/APL1C and
TEP1cut and subsequent recruitment of SPCLIP1. An unknown catalytically active protease is then recruited generating the mature TEP1 convertase,
which processes TEP1-F causing it to rapidly interact with nearby surfaces. Steady state processing of TEP1-F and that performed by the TEP1
convertase are distinct, as only the latter requires SPCLIP1. Formation of the TEP1 convertase is required for phagocytosis, lysis, or CLIPA8 cleavage by
an unknown protease and subsequent activation of the melanization cascade.
doi:10.1371/journal.ppat.1003623.g007
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serum-free medium (Invitrogen) stably secreting SPCLIP1HIS were
generated by selection with 1 mg/mL G418 following co-
transfection using Escort IV (Sigma) of pIEx10-SPCLIP1HIS and
pIE1-neo (Novagen). Clones of resistant cells were analyzed by
western blot for the presence of SPCLIP1HIS in their conditioned
medium and the line with the highest expression was chosen for
protein production. SPCLIP1HIS was purified from 500 mL of
conditioned medium using a 1 mL HisTrap column attached to
an A¨KTA purifier (GE Healthcare). Bound protein was eluted in
15 mL of PBS containing 500 mM imidazole pH 8.0. Purified
SPCLIP1HIS was quantified by Bradford assay and by coomassie
staining of SDS-PAGE gels. The purified protein was used to
generate a rabbit polyclonal antibody (Eurogentec). SPCLIP1
antibody was affinity purified from the positive immune serum by
passage over an AminoLink column (Pierce) containing covalently
bound SPCLIP1HIS.
Bioparticles challenge
A 20 mg/mL suspension of fluorescein or pHrodo labeled E. coli
K-12 strain bacterial bioparticles (Invitrogen) in sterile PBS was
injected into the mosquito hemocoel (,46105 bacteria in 69 nL).
Hemolymph was collected directly into non-reducing SDS-PAGE
sample buffer from groups of 30–40 mosquitoes 15, 60, 120, 240
and 360 min after the challenge and analyzed by reducing and
non-reducing western as described previously [5]. Bioparticles
surface extraction was performed by collecting in protein LoBind
tubes (Eppendorf) hemolymph from 60 mosquitoes into 60 mL of
15 mM Tris (pH 8.0) containing 16 protease inhibitor cocktail
(complete EDTA free, Roche) 15 min after bacterial injection.
The soluble (unbound) fraction was collected after pelleting the
bacteria by centrifugation for 4 min at 6000 g at 4uC and then
supplemented with SDS-PAGE buffer. The bacterial pellet
was washed with 400 mL of 15 mM Tris (pH 8.0) and the
bound fraction was extracted with 25 mL SDS-PAGE sample
buffer. Western blot analysis was performed using 25 mL of each
sample.
Immunoprecipitation and western analysis
Western blot analysis for TEP1, LRIM1/APL1C, SRPN3,
CLIPA8 and PPO6 was performed as previously described [5,21].
The affinity purified rabbit a-SPCLIP1 antibody was used to
probe western blots at a 1:1000 dilution of antibody in PBS
containing 0.05% Tween 20 and 3% milk for 1 h at room
temperature using. Co-immunoprecipitation reactions were per-
formed using the Pierce Co-IP kit according to the manufacturer’s
protocol (ThermoScientific). Hemolymph was collected from 100
mosquitoes into 200 mL ice-cold PBS containing 0.05% Triton X-
100, supplemented with 16 protease inhibitor cocktail 15 min
after PBS or E. coli bioparticle injection (69 nL of 4 mg/mL;
,86104 particles). The samples were centrifuged at 4000 g for
5 min to remove mosquito and bacterial cells. 40 mL of a 1:1
slurry of PBS and agarose beads containing crosslinked affinity
purified a-SPCLIP1 antibody or control beads were added to the
cleared hemolymph samples and mixed overnight at 4uC on a
rotating wheel. The unbound fraction was collected and supple-
mented with SDS-PAGE buffer. Then the beads were washed five
times with collection buffer and bound material was eluted two
times with 100 mL of elution buffer (0.2% SDS and 0.1% Tween-
20 in 50 mM Tris pH 8.0). The eluents were pooled and
supplemented with SDS-PAGE buffer. Western blot analysis was
performed by loading 40 mL of each sample. Reducing samples
were made by addition of 2-mercaptoethanol to a final concen-
tration of 2.5%.
PPO activation and CLIPA8 cleavage
Cleavage of CLIPA8 was assayed in samples of hemolymph
analyzed under reducing conditions as described previously [21].
PPO activation was determined assaying the conversion of L-
DOPA to Dopachrome in samples of mosquito hemolymph
collected after bacterial challenge [36].
Immunolocalization of TEP1 and SPCLIP1
TEP1 and SPCLIP1 were immunolocalization to ookinetes
26 h after P. berghei infection. Mosquito midguts were prepared
and analyzed as previously described [5]. The SPCLIP1 antibody
was used at a 1:250 dilution. Images were acquired on a Zeiss
LSM 710 META confocal.
VectorBase gene identifiers
LRIM1, AGAP006348; APL1C, AGAP007033; TEP1,
AGAP010815; TEP4, AGAP010812; CLIPA1, AGAP011791;
CLIPA2, AGAP011790; CLIPA4, AGAP011780; CLIPA5,
AGAP011787; CLIPA6, AGAP011789; CLIPA7, AGAP011792;
CLIPA8, AGAP010731; CLIPA9, AGAP010968; CLIPA12,
AGAP011781; CLIPA13, AGAP011783; CLIPA14, AGAP011
788; CLIPB2, AGAP003246; CLIPB3, AGAP003249; CLIPB4,
AGAP003250; CLIPB8, AGAP003057; CLIPB9, AGAP013442;
CLIPB10, AGAP003058; CLIPB13, AGAP004855; CLIPB14,
AGAP010833; CLIPB15, AGAP009844; CLIPC1, AGAP008835;
CLIPC2, AGAP004317; CLIPC3, AGAP004318; CLIPC5,
AGAP000571; CLIPC6, AGAP000315; CLIPC9, AGAP004719;
CLIPC10, AGAP000572; CLIPD4, AGAP002811; CLIPD6,
AGAP002813; CLIPD7, AGAP008998; CLIPD8, AGAP002784;
CLIPE2, AGAP011782; CLIPE4, AGAP010530; CLIPE5,
AGAP010547; CLIPE6, AGAP011785; CLIPE7, AGAP011786;
PPO6, AGAP004977; CTL4, AGAP005335; SRPN3, AGA
P006910.
Supporting Information
Figure S1 SPCLIP1 genomic organization, multiple
sequence alignment, and phylogenetic analysis. (A) In
the top diagram genes are indicated above and below a 55 kb
region of A. gambiae chromosome 3L depending on whether they
are encoded by the positive or negative DNA strand, respectively.
The bottom diagram shows an expanded view of an 8.2 kb region
indicated in red in the top diagram to illustrate the experimentally
derived intron-exon boundaries of SPCLIP1 and its tail-to-tail
orientation with CLIPA7. Coding regions are depicted with dark
gray boxes, untranslated regions with white boxes, and introns
with black lines. Features within both diagrams are drawn to scale.
The SPCLIP1 gene does not correspond to any gene model in the
A. gambiae genome annotation and is only present as a SNAP
prediction. (B) Alignment of SPCLIP1 with representative
members of the CLIP subfamilies A–D. The N-terminal CLIP
domain is indicated by a blue background. Shaded residues
indicate consensus similarity, light gray; consensus identity, dark
gray; conserved cysteine, yellow; CLIPA and SPCLIP1 conserved
tyrosine, red. Stars indicate the positions of the catalytic triad
residues and lines connect cysteines involved intramolecular
disulfide bonds. The black outline indicates the predicted
activation cleavage position in the CLIPB, C and D zymogens.
(C) Unrooted tree generated from analysis of the protease domain
of 35 members of the A. gambiae CLIP family. Colored regions
highlight the major subfamilies: CLIPA, yellow; CLIPB, blue;
CLIPC, green; CLIPD, orange. White circles indicate bootstrap
values .80.
(TIF)
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Figure S2 TEP1 is required for CLIPA8 and PPO
activation. (A) Reducing western analysis of CLIPA8 in
hemolymph collected from control dsLacZ injected and TEP1
and CLIPA8 kd mosquitoes after injection with E. coli bioparticles.
CLIPA8-C indicates the CLIPA8 cleavage product which is
markedly reduced in TEP1 silenced mosquitoes. Blot was re-
probed with an antibody against SRPN3 to confirm equal loading.
(B) PO activity measured in hemolymph samples collected from
dsTEP1, dsCLIPA8 and control dsLacZ treated mosquitoes 6 h
after injection with bacteria.
(TIF)
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